A137 THERAPEUTIC DRUG MONITORING WITH INFLIXIMAB TROUGH LEVELS LEAD TO INCREASED INTERVENTION

BACKGROUND: Therapeutic drug monitoring (TDM) of infliximab (IFX) as indicated in patients with loss of response (LOR) (known as reactive strategy) is a widely accepted strategy in the management of patients with inflammatory bowel disease (IBD). Proactive drug monitoring of IFX trough levels has be...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Can Assoc Gastroenterol
Hlavní autoři: Stern, N C, Fedorak, R, Wong, K, Halloran, B P, Dieleman, L A, Huang, V, Peerani, F, Kroeker, K I
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Paper Sessions
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508429/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.137
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky